Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Identifying and inhibiting novel signalling pathways involved in the amplification of C/EBPá expression as a means to prevent muscle wasting in cancer.

FY 2019-20

Summary
"Cancer cachexia is a neurological syndrome caused by the presence of tumour cells in the body that leads to a severe wasting of skeletal muscle in patients. The exact cause of this phenomenon is likely to be multifactorial and is currently being investigated by the Wiper-Bergeron laboratory. The most recent findings have shown that CCAAT/Enhancer Binding Protein beta (C/EBPβ) plays a central role in the development of muscle wasting observed in cancer cachexia. Our laboratory has demonstrated that cachexia-inducing tumors (e.g. Lewis Lung Carcinoma) express high levels of C/EBPβ, while non-cachexia tumours have lower expression. Tumour-derived factors promote muscle catabolism and recent evidence suggests that a combination of secreted factors underlies wasting in cancer patients. C/EBPβ is a central factor in regulating proteins secreted by tumours in muscle wasting, highlighting the importance of further inquiry into its mechanism of action. We hypothesize that tumours expressing C/EBPβ produce cachexia-inducing factors that directly cause muscle wasting, but also stimulate the expression of C/EBPβ in secondary tissues, thereby amplifying the cachectic signal. The aims of this project are twofold: (1) To identify the factors regulated by C/EBPβ responsible for induction of cachexia and (2) To determine if induction of C/EBPβ in non-muscle tissues in tumour-bearing animals leads to amplification of the cachectic signal. Our research will significantly enrich the current knowledge on the mechanism behind C/EBPβ-mediated cachectic signal amplification that leads to muscle wasting in cancer patients. The findings will have implications in the identification of drugs for prevention and treatment of cancer cachexia, with the primary goal of increasing patients' survival."
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
428669
Name
Alexeev Konstantin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying and inhibiting novel signalling pathways involved in the amplification of C/EBPá expression as a means to prevent muscle wasting in cancer.
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adipose Tissue; Bone; Bone Marrow; Cachectic Signal Amplification; Cancer Cachexia; Ccaat-Enhancer Binding Protein Beta; Muscle Differentiation; Muscle Proteins; Muscle Wasting; Skeletal Muscle
Abstract
"Cancer cachexia is a neurological syndrome caused by the presence of tumour cells in the body that leads to a severe wasting of skeletal muscle in patients. The exact cause of this phenomenon is likely to be multifactorial and is currently being investigated by the Wiper-Bergeron laboratory. The most recent findings have shown that CCAAT/Enhancer Binding Protein beta (C/EBPβ) plays a central role in the development of muscle wasting observed in cancer cachexia. Our laboratory has demonstrated that cachexia-inducing tumors (e.g. Lewis Lung Carcinoma) express high levels of C/EBPβ, while non-cachexia tumours have lower expression. Tumour-derived factors promote muscle catabolism and recent evidence suggests that a combination of secreted factors underlies wasting in cancer patients. C/EBPβ is a central factor in regulating proteins secreted by tumours in muscle wasting, highlighting the importance of further inquiry into its mechanism of action. We hypothesize that tumours expressing C/EBPβ produce cachexia-inducing factors that directly cause muscle wasting, but also stimulate the expression of C/EBPβ in secondary tissues, thereby amplifying the cachectic signal. The aims of this project are twofold: (1) To identify the factors regulated by C/EBPβ responsible for induction of cachexia and (2) To determine if induction of C/EBPβ in non-muscle tissues in tumour-bearing animals leads to amplification of the cachectic signal. Our research will significantly enrich the current knowledge on the mechanism behind C/EBPβ-mediated cachectic signal amplification that leads to muscle wasting in cancer patients. The findings will have implications in the identification of drugs for prevention and treatment of cancer cachexia, with the primary goal of increasing patients' survival."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Alexeev, Konstantin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~